StockWatch
·
Biotechnology
Acquisitions19 Nov 2026, 02:50 pm

Advanced Enzyme Increases Stake in JC Biotech to 96.94%

AI Summary

Advanced Enzyme Technologies Ltd has completed the acquisition of an additional 1.22% stake in its subsidiary, JC Biotech Private Limited (JCB), for a consideration of ₹22.80 million (₹90 per Equity Share). This increases the company's shareholding in JCB from 95.72% to 96.94%. Advanced Enzyme is also in the process of acquiring the remaining 3.06% stake, which would make JCB a wholly-owned subsidiary. The effective date of the increased shareholding is November 18, 2026.

Key Highlights

  • Acquired additional 1.22% stake in subsidiary JC Biotech Private Limited.
  • Shareholding in JC Biotech increased from 95.72% to 96.94%.
  • Acquisition cost was ₹22.80 million.
  • Company aims to make JC Biotech a wholly-owned subsidiary.